• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中 VPS35 突变的筛查。

Screening for VPS35 mutations in Parkinson's disease.

机构信息

Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.

出版信息

Neurobiol Aging. 2012 Apr;33(4):838.e1-5. doi: 10.1016/j.neurobiolaging.2011.10.032. Epub 2011 Dec 7.

DOI:10.1016/j.neurobiolaging.2011.10.032
PMID:22154191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3629567/
Abstract

Recently 2 groups have independently identified a mutation in the gene 'vacuolar protein sorting 35 homolog' (VPS35 c.1858G>A; p.Asp620Asn) as a possible cause of autosomal dominant Parkinson's disease (PD). In order to assess the frequency of the reported mutation and to search for other possible disease-causing variants in this gene, we sequenced all 17 exons of VPS35 in 96 familial PD cases, and exon 15 (in which the reported mutation is found) in an additional 64 familial PD cases, 175 young-onset PD cases, and 262 sporadic, neuropathologically confirmed PD cases. We identified 1 individual with the p.Asp620Asn mutation and an autosomal dominant family history of PD. Subsequent follow-up of the family confirmed an affected sibling and cousin who also carried the same mutation. No other potentially disease-causing mutations were identified. We conclude that the VPS35 c.1858G>A mutation is an uncommon cause of familial Parkinson's disease in our population.

摘要

最近有 2 组独立鉴定出基因“液泡蛋白分选 35 同源物”(VPS35 c.1858G>A;p.Asp620Asn)中的突变可能是常染色体显性帕金森病(PD)的一个原因。为了评估报道的突变的频率,并在该基因中寻找其他可能的致病变体,我们对 96 例家族性 PD 病例的 VPS35 的所有 17 个外显子以及另外 64 例家族性 PD 病例、175 例早发性 PD 病例和 262 例散发性、神经病理学确诊的 PD 病例的外显子 15(报道的突变发生在其中)进行了测序。我们发现了 1 例携带 p.Asp620Asn 突变的个体,以及 PD 的常染色体显性家族史。对该家族的后续随访证实了一名受影响的兄弟姐妹和表亲也携带相同的突变。未发现其他潜在的致病突变。我们的结论是,VPS35 c.1858G>A 突变在我们的人群中是家族性帕金森病的一个不常见原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1834/3629567/47e4e76ac976/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1834/3629567/47e4e76ac976/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1834/3629567/47e4e76ac976/gr1.jpg

相似文献

1
Screening for VPS35 mutations in Parkinson's disease.帕金森病中 VPS35 突变的筛查。
Neurobiol Aging. 2012 Apr;33(4):838.e1-5. doi: 10.1016/j.neurobiolaging.2011.10.032. Epub 2011 Dec 7.
2
Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease.空泡蛋白分选 35 号天冬氨酸 620 号天冬酰胺突变在帕金森病的华裔人群中罕见。
Parkinsonism Relat Disord. 2012 Jun;18(5):638-40. doi: 10.1016/j.parkreldis.2012.02.011. Epub 2012 Mar 10.
3
VPS35 mutation in Japanese patients with typical Parkinson's disease.日本典型帕金森病患者中 VPS35 突变。
Mov Disord. 2012 Sep 15;27(11):1413-7. doi: 10.1002/mds.25145. Epub 2012 Sep 18.
4
VPS35 gene variants are not associated with Parkinson's disease in the mainland Chinese population.VPS35 基因变异与中国大陆人群的帕金森病无关。
Parkinsonism Relat Disord. 2012 Sep;18(8):983-5. doi: 10.1016/j.parkreldis.2012.05.002. Epub 2012 Jun 4.
5
VPS35 and EIF4G1 mutations are rare in Parkinson's disease among Indians.VPS35 和 EIF4G1 突变在印度人群中的帕金森病中较为罕见。
Neurobiol Aging. 2013 Oct;34(10):2442.e1-3. doi: 10.1016/j.neurobiolaging.2013.04.025. Epub 2013 May 28.
6
Frequency of the ASP620ASN mutation in VPS35 and Arg1205His mutation in EIF4G1 in familial Parkinson's disease from South Italy.意大利南部家族性帕金森病中VPS35基因ASP620ASN突变及EIF4G1基因Arg1205His突变的频率
Neurobiol Aging. 2014 Oct;35(10):2422.e1-2. doi: 10.1016/j.neurobiolaging.2014.04.020. Epub 2014 Apr 26.
7
VPS35 Parkinson's disease phenotype resembles the sporadic disease.VPS35帕金森病表型类似于散发性疾病。
J Neural Transm (Vienna). 2014 Jul;121(7):755-9. doi: 10.1007/s00702-014-1179-1. Epub 2014 Feb 21.
8
Identification of VPS35 p.D620N mutation-related Parkinson's disease in a Taiwanese family with successful bilateral subthalamic nucleus deep brain stimulation: a case report and literature review.在一个成功接受双侧丘脑底核深部脑刺激的台湾家庭中鉴定VPS35 p.D620N突变相关的帕金森病:病例报告及文献综述
BMC Neurol. 2017 Oct 6;17(1):191. doi: 10.1186/s12883-017-0972-5.
9
D620N mutation in the VPS35 gene and R1205H mutation in the EIF4G1 gene are uncommon in the Greek population.VPS35基因中的D620N突变和EIF4G1基因中的R1205H突变在希腊人群中并不常见。
Neurosci Lett. 2015 Oct 8;606:113-6. doi: 10.1016/j.neulet.2015.08.020. Epub 2015 Aug 20.
10
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.VPS35 基因突变导致晚发性帕金森病,VPS35 编码的是逆行转运复合体的一个亚基。
Am J Hum Genet. 2011 Jul 15;89(1):168-75. doi: 10.1016/j.ajhg.2011.06.008.

引用本文的文献

1
Identification of high-performing antibodies for Vacuolar protein sorting-associated protein 35 (hVPS35) for use in Western Blot, immunoprecipitation and immunofluorescence.鉴定用于蛋白质免疫印迹、免疫沉淀和免疫荧光的液泡蛋白分选相关蛋白35(hVPS35)的高效抗体。
F1000Res. 2023 Oct 16;12:452. doi: 10.12688/f1000research.133696.2. eCollection 2023.
2
Endemic parkinsonism: clusters, biology and clinical features.地方性帕金森病:集群、生物学和临床特征。
Nat Rev Neurol. 2023 Oct;19(10):599-616. doi: 10.1038/s41582-023-00866-3. Epub 2023 Sep 8.
3
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's disease.

本文引用的文献

1
A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.VPS35 基因突变导致晚发性帕金森病,VPS35 编码的是逆行转运复合体的一个亚基。
Am J Hum Genet. 2011 Jul 15;89(1):168-75. doi: 10.1016/j.ajhg.2011.06.008.
2
VPS35 mutations in Parkinson disease.帕金森病中的 VPS35 突变。
Am J Hum Genet. 2011 Jul 15;89(1):162-7. doi: 10.1016/j.ajhg.2011.06.001.
3
Olfactory dysfunction in LRRK2 G2019S mutation carriers.LRRK2 G2019S 突变携带者的嗅觉功能障碍。
VPS35 和 α-突触核蛋白未能相互作用以调节帕金森病啮齿动物模型中的神经退行性变。
Mol Neurodegener. 2023 Aug 4;18(1):51. doi: 10.1186/s13024-023-00641-4.
4
A Practical Approach to Early-Onset Parkinsonism.早发性帕金森病的实用处理方法。
J Parkinsons Dis. 2022;12(1):1-26. doi: 10.3233/JPD-212815.
5
Unveiling the cryo-EM structure of retromer.揭示返回蛋白的冷冻电镜结构。
Biochem Soc Trans. 2020 Oct 30;48(5):2261-2272. doi: 10.1042/BST20200552.
6
Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease.家族性和散发性帕金森病中的嗅觉功能障碍
Front Neurol. 2020 May 29;11:447. doi: 10.3389/fneur.2020.00447. eCollection 2020.
7
Long-Term Outcomes of Genetic Parkinson's Disease.遗传性帕金森病的长期预后
J Mov Disord. 2020 May;13(2):81-96. doi: 10.14802/jmd.19080. Epub 2020 May 29.
8
Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.在源自患者的脑细胞中揭示帕金森病的遗传易感性。
NPJ Parkinsons Dis. 2020 Apr 24;6:8. doi: 10.1038/s41531-020-0110-8. eCollection 2020.
9
The Role of VPS35 in the Pathobiology of Parkinson's Disease.VPS35 在帕金森病发病机制中的作用。
Cell Mol Neurobiol. 2021 Mar;41(2):199-227. doi: 10.1007/s10571-020-00849-8. Epub 2020 Apr 22.
10
VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease.基于VPS35的方法:帕金森病一种潜在的创新治疗方法。
Front Neurol. 2019 Dec 17;10:1272. doi: 10.3389/fneur.2019.01272. eCollection 2019.
Neurology. 2011 Jul 26;77(4):319-24. doi: 10.1212/WNL.0b013e318227041c. Epub 2011 Jul 13.
4
A two-stage meta-analysis identifies several new loci for Parkinson's disease.一项两阶段荟萃分析确定了几个帕金森病的新发病位点。
PLoS Genet. 2011 Jun;7(6):e1002142. doi: 10.1371/journal.pgen.1002142. Epub 2011 Jun 30.
5
Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.对序列变异进行推断以识别帕金森病的遗传风险:全基因组关联研究的荟萃分析。
Lancet. 2011 Feb 19;377(9766):641-9. doi: 10.1016/S0140-6736(10)62345-8. Epub 2011 Feb 1.
6
Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study.帕金森病杂合子和复合杂合子患者的嗅觉:CORE-PD 研究。
Neurology. 2011 Jan 25;76(4):319-26. doi: 10.1212/WNL.0b013e31820882aa. Epub 2010 Dec 29.
7
Olfactory heterogeneity in LRRK2 related Parkinsonism.LRRK2 相关性帕金森病嗅觉异质性。
Mov Disord. 2010 Dec 15;25(16):2879-83. doi: 10.1002/mds.23325.
8
The clinical progression of Parkinson's disease.帕金森病的临床进展。
Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S28-32. doi: 10.1016/S1353-8020(09)70831-4.
9
The use of a color coded probability scale to interpret smell tests in suspected parkinsonism.使用颜色编码概率量表来解释疑似帕金森病患者的嗅觉测试结果。
Mov Disord. 2009 Jun 15;24(8):1144-53. doi: 10.1002/mds.22494.
10
Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.G2019S 型富亮氨酸重复激酶 2 相关帕金森综合征中的嗅觉减退:临床和病理数据
Neurology. 2008 Sep 23;71(13):1021-6. doi: 10.1212/01.wnl.0000326575.20829.45.